These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3957664)

  • 1. [Local and transcutaneous pharmacotherapy. Pharmacokinetic principles and clinical evaluation].
    Stüttgen G; Täuber U; Bauer E; Zesch A
    Hautarzt; 1986 Feb; 37(2):65-76. PubMed ID: 3957664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical use of inorganic mercury compounds].
    Merk HF
    Hautarzt; 1992 Dec; 43(12):798-9. PubMed ID: 1473976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatological local therapy. How to control eczema].
    Niedner R; Iliev D
    MMW Fortschr Med; 2001 Jun; 143(24):33-8. PubMed ID: 11469016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical therapy--risks and unwanted effects].
    Zesch A
    Z Hautkr; 1986 Jun; 61(11):821-3. PubMed ID: 3739399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of transcutaneous absorption. Pharmacologic and biochemical aspects].
    Karzel K; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1487-91. PubMed ID: 2696464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance for silicone protective agents for skin application].
    Ievleva EA; Aliushin MT; Gritsaenko IS; Astrakhanova MM; Barbéroshie IE
    Farmatsiia; 1976; 25(5):53-6. PubMed ID: 1001486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Percutaneous absorption: topical and systemic treatments].
    Machet L; Baïcan A; Pelucio-Lopes C; Patat F; Vaillant L
    Ann Dermatol Venereol; 1997; 124(6-7):490-6. PubMed ID: 9739917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
    Giannetti A; Laria G; Seidenari S
    Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urea in topical therapy of skin diseases--principles and use].
    Wohlrab WA
    Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial experience with Natuderm a new skin film emulsion analogue cream.
    Maisey AR; Brook JH
    Br J Clin Pract; 1980 Jun; 34(6):178-81. PubMed ID: 7437282
    [No Abstract]   [Full Text] [Related]  

  • 12. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Staab D; Pariser D; Gottlieb AB; Kaufmann R; Eichenfield LF; Langley RG; Scott G; Ebelin ME; Barilla D; Schmidli H; Burtin P
    Pediatr Dermatol; 2005; 22(5):465-71. PubMed ID: 16191004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and efficacy of skin medications].
    Stüttgen G
    Hautarzt; 1981 Apr; 32(4):199-207. PubMed ID: 6112211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atopic dermatitis in young skin].
    Rev Infirm; 2004 Dec; (106):12-5. PubMed ID: 15672515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Volon A shake mix--a promising innovation].
    Brinkmann W
    Z Hautkr; 1983 Nov; 58(21):1539-41. PubMed ID: 6689239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptors and unsaturated fatty acids: implications for pharmacologic activity of the galenic forms of topical preparations.
    Reichrath J
    Dermatology; 2004; 209(4):348-9. PubMed ID: 15539909
    [No Abstract]   [Full Text] [Related]  

  • 19. [Special requirements for topical therapy in infants].
    Wohlrab J
    MMW Fortschr Med; 2008 Jun; 150(25):36-7. PubMed ID: 18705053
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.